North Dakota Statutes
§ 23-48-02 — Drug manufacturers - Availability of investigational drugs, biological products, or devices - Costs - Insurance coverage
products, or devices - Costs - Insurance coverage.
1.A manufacturer of an investigational drug, biological product, or device may make
available the manufacturer's investigational drug, biological product, or device to an
eligible patient pursuant to this chapter. This chapter does not require that a
manufacturer make available to an eligible patient an investigational drug, biological
product, or device.
2.A manufacturer may:
a.Provide to an eligible patient an investigational drug, biological product, or device
without receiving compensation; or
b.Require an eligible patient to pay the costs of, or the costs associated with, the
manufacture of the investigational drug, biological product, or device.
3.If an eligible patient dies while being treated by an investigational drug, biolog
Free access — add to your briefcase to read the full text and ask questions with AI
North Dakota § 23-48-02 (Drug manufacturers - Availability of investigational drugs, biological products, or devices - Costs - Insurance coverage) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Nearby Sections
15
§ 23-01-01
Health division - Officers§ 23-01-01.1
Department of health and human services to replace state department of health and consolidated laboratories§ 23-01-02.1
Hospital utilization committees - Internal quality assurance review committees - Reports - Immunity§ 23-01-03
Powers and duties of the health council§ 23-01-03.2
Duties of the health council§ 23-01-04
Effect of rules and regulations§ 23-01-04.1
Rulemaking authority and procedure§ 23-01-04.2
Legislative intent - Health vaccination charges